Related Experiment Video
Updated: May 22, 2026

10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Distribution of methylone in four postmortem cases.
Brian M Cawrse1, Barry Levine, Rebecca A Jufer
1Office of the Chief Medical Examiner, 900 W. Baltimore St., Baltimore, MD 21223, USA. briancawrse@me.com
Journal of Analytical Toxicology
|May 15, 2012
Summary
New psychoactive substances like methylone, mephedrone, and MDPV are sold as legal alternatives. Postmortem analysis confirmed methylone in all cases, indicating its presence in fatalities and suitability for toxicological testing.
Area of Science:
- Forensic Toxicology
- Pharmacology
- Analytical Chemistry
Background:
- Novel psychoactive substances (NPS) derived from amphetamines are increasingly prevalent.
- These substances, including methylone, mephedrone, and MDPV, are often marketed as legal alternatives to controlled stimulants.
- Understanding their postmortem behavior is crucial for forensic investigations.
Observation:
- Analysis of four postmortem cases revealed detectable levels of methylone in all subjects.
- Methylone concentrations in heart blood varied, with levels ranging from 0.060 to 1.12 mg/L.
- MDPV was detected in two cases, though further data is needed for sequestration analysis.
Findings:
- Methylone did not show significant sequestration in specific tissue types postmortem.
- An average liver-to-blood ratio of 2.68 was calculated for methylone.
- The study demonstrated methylone's suitability for toxicological analysis using different extraction and derivatization methods.
- One case suggested potential chronic methylone use, evidenced by a urine concentration of 38 mg/L.
Implications:
- These findings aid in the accurate toxicological assessment of fatalities involving NPS.
- The suitability for analysis across methods supports routine forensic screening.
- Further research is warranted to understand the long-term effects and postmortem dynamics of these emerging drugs.

